Acute Myeloid Leukemia: Examining the Pharmacologic Profiles and Integration of Treatment Advances
0 Views
administrator
07/04/23
Earn CME for related activities: https://www.naccme.com/oln
Featuring a presentation by Dr. Christopher A. Fausel, this on-demand webcast examines novel chemotherapeutic formulations and targeted agents in the treatment of AML in terms of clinical outcomes, pharmacologic profiles, reduced toxicity, and pharmacoeconomic data.
ยฉ 2018 NACCME, an HMP Company
-
Category
Show more
Facebook Comments
No comments found